Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium chloride + potassium chloride + sodium lactate + sodium chloride + dextrose monohydrate is an intravenous crystalloid electrolyte-and-carbohydrate solution generally marketed as **Lactated Ringer's and Dextrose 5% Injection**. It supplies water, sodium, potassium, calcium, chloride, lactate, and dextrose; the electrolytes expand and replenish extracellular fluid, dextrose provides carbohydrate calories, and lactate is metabolized to bicarbonate equivalents that can provide an alkalinizing effect. It is indicated as a source of water, electrolytes, and calories and as an alkalinizing agent in adults and pediatric patients. The specified ingredient list can encompass products with different potassium chloride concentrations, including standard Lactated Ringer's and Dextrose formulations and potassium-supplemented formulations. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6acc9f96-7088-45a7-b48f-1a861e3467ab))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium chloride + potassium chloride + sodium lactate + sodium chloride + dextrose monohydrate.